Search research articles
Contact Us
Filters
Showing results (671-680 of 674) with videos related to
Page
of 68
Sort By:
You have reached the last page of results.
This site can display upto 674 results.
Nature Genetics
|
June 28, 2016
Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax
Daniel N Hupalo, Zunping Luo, Alexandre Melnikov, et al.
Scientific Reports
|
July 2, 2021
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors
Matthew S Dietz, Thomas L Sutton, Brett S Walker, et al.
Bone Marrow Transplantation
|
January 10, 2001
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
M Michallet, X Thomas, J P Vernant, et al.
JAMA Oncology
|
February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
Andrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Page
of 68
Search research articles
Search
Showing results (671-680 of 674) with videos related to
Sort By:
Page
of 68
You have reached the last page of results.
This site can display upto 674 results.
Nature Genetics
|
June 28, 2016
Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax
Daniel N Hupalo, Zunping Luo, Alexandre Melnikov, et al.
Scientific Reports
|
July 2, 2021
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors
Matthew S Dietz, Thomas L Sutton, Brett S Walker, et al.
Bone Marrow Transplantation
|
January 10, 2001
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
M Michallet, X Thomas, J P Vernant, et al.
JAMA Oncology
|
February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
Andrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Page
of 68